Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Enbrel Etanercept 25mg Powder for injection with diluent Pfizer New Zealand Limited Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Enbrel Etanercept 50mg Powder for injection with diluent Pfizer New Zealand Limited Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Enbrel Etanercept 25mg Solution for injection Pfizer New Zealand Limited Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany Pfizer Ireland Pharmaceuticals, Dublin, Ireland Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Enbrel Etanercept 50mg Solution for injection Pfizer New Zealand Limited Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany Pfizer Ireland Pharmaceuticals, Dublin, Ireland Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Dated this 10th day of December 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).